Á. Puente

发表

Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It

S. Llerena, J. Crespo, E. Fábrega, 2019, Cells.

Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease

S. Llerena, J. Crespo, D. San Segundo, 2016, International Journal of Molecular Sciences.

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.

X. Forns, J. Calleja, J. García‐Pagán, 2020, Journal of hepatology.

LOXL2—A New Target in Antifibrogenic Therapy?

S. Llerena, J. Crespo, E. Fábrega, 2019, International journal of molecular sciences.

Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.

X. Forns, J. Calleja, J. García‐Pagán, 2017, Gastroenterology.

Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapy.

J. Crespo, E. Fábrega, J. Cabezas, 2017, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey.

S. Llerena, J. Crespo, E. Fábrega, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review

M. Poca, I. Gich, V. Hernández-Gea, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Prognostic Markers in Patients with Cirrhosis and Portal Hypertension Who Have Not Bled

M. Poca, C. Villanueva, I. Graupera, 2011, Disease markers.

Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis

A. de Gottardi, D. Semela, D. Valla, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain

J. Crespo, E. Fábrega, A. Cuadrado, 2020, Journal of clinical medicine.

Congestive Hepatopathy

J. Crespo, E. Fábrega, A. Cuadrado, 2020, International journal of molecular sciences.

Cardiac Hepatopathy

J. Crespo, E. Fábrega, A. Cuadrado, 2019, Liver Pathology.

Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis

M. Poca, J. Calleja, J. Genescà, 2021, Journal of clinical medicine.

Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy

S. Llerena, J. Crespo, E. Fábrega, 2019, Journal of clinical medicine.

SARS-CoV-2 and Liver Transplant: How Has It Behaved in This Sixth Wave?

J. Crespo, D. San Segundo, M. López-Hoyos, 2022, Transplantation.

Number of Antibody-verified Eplet in HLA-C Locus as an Independent Factor of T-cell–Mediated Rejection After Liver Transplantation

J. Crespo, M. López-Hoyos, E. Fábrega, 2020, Transplantation.

Impact of an acute hemodynamic response-guided protocol for primary prophylaxis of variceal bleeding

S. Llerena, J. Crespo, E. Fábrega, 2018, World journal of clinical cases.

Non-invasive tests for clinically significant portal hypertension after HCV cure.

H. Yoshiji, X. Forns, E. Tsochatzis, 2022, Journal of hepatology.

Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy.

S. Llerena, J. Crespo, E. Fábrega, 2015, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis

M. Poca, V. Hernández-Gea, J. Miñana, 2017, Hepatology.

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

J. Mateo, A. Berzigotti, J. García‐Pagán, 2017 .

Epidemiology and clinical course of hepatitis A in Cantabria before and after the epidemic outbreak of June 2016

S. Llerena, E. Fábrega, A. Cuadrado, 2020 .

Plasma betatrophin levels in patients with liver cirrhosis.

S. Llerena, J. Crespo, E. Fábrega, 2015, World journal of gastroenterology.

De Novo Donor-Specific Anti-Human Leukocyte Antigen Antibody Detection in Long-Term Adult Liver Transplantation.

J. Crespo, D. San Segundo, M. López-Hoyos, 2016, Transplantation proceedings.

Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review

E. Fábrega, A. Cuadrado, J. I. Fortea, 2022, Journal of clinical medicine.

Impact of anticoagulation on upper‐gastrointestinal bleeding in cirrhosis. A retrospective multicenter study

M. Casas, J. García‐Pagán, J. Genescà, 2015, Hepatology.

Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases

J. García‐Pagán, V. Hernández-Gea, A. Albillos, 2021, Clinical Gastroenterology and Hepatology.

Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders

J. Crespo, E. Fábrega, A. Cuadrado, 2020, Journal of clinical medicine.

Binge drinking: Burden of liver disease and beyond.

S. Llerena, J. Crespo, E. Fábrega, 2015, World journal of hepatology.

Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

A. de Gottardi, F. Nevens, J. Trebicka, 2022, Transplantation.

Immune Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Liver Transplant Recipients

J. Crespo, D. San Segundo, M. López-Hoyos, 2022, Transplantation.

Periprocedural management of hemostatic alterations in patients with cirrhosis and vascular liver disorders: a step forward of the American Association for the Study of Liver Diseases

E. Fábrega, J. I. Fortea, Á. Puente, 2023, Hepatobiliary surgery and nutrition.

Cirrhosis, a Global and Challenging Disease

J. I. Fortea, Á. Puente, J. Crespo, 2022, Journal of clinical medicine.

Decompensation in advanced non-alcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels that in patients with viral disease.

X. Forns, J. Trebicka, W. Laleman, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic‐associated fatty liver disease

E. Fábrega, A. Cuadrado, P. Iruzubieta, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR

I. Varela, M. Piris, B. Crespo-Facorro, 2018, Oncotarget.

Galectin-1 in stable liver transplant recipients.

S. Llerena, J. Crespo, D. San Segundo, 2015, Transplantation Proceedings.

CD64 expression on neutrophils as a potential biomarker for bacterial infection in ascitic fluid of cirrhotic patients

D. San Segundo, M. López-Hoyos, J. I. Fortea, 2023, Infectious Diseases.

Non‐malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors

J. Calleja, J. Crespo, J. Abad, 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis

A. de Gottardi, D. Semela, D. Valla, 2017, Liver international : official journal of the International Association for the Study of the Liver.